A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro

by Yu-jie Xing, Yu-jie Xing, Biao-hu Liu, Shu-jun Wan, Shu-jun Wan, Yi Cheng, Yi Cheng, Si-min Zhou, Si-min Zhou, Yue Sun, Yue Sun, Xin-ming Yao, Qiang Hua, Xiang-jian Meng, Jin-han Cheng, Min Zhong, Min Zhong, Yan Zhang, Kun Lv, Kun Lv, Xiang Kong, Xiang Kong, Xiang Kong
Published 2021-07-01